Xtant Medical closes $6.75M first tranche of private placement; appoints Vizirgianakis Chairman

Xtant Medical Holdings, Inc.

First tranche: sold 14.1M shares and warrants for 3.5M shares at ~$6.75M to accredited investors.
Second tranche of ~$3.0M (6.2M shares + 1.6M warrants) expected early October 2022.
Board expanded to 7 directors; Stavros Vizirgianakis elected Chairman, replacing Jeffrey Peters.
2022 Annual Meeting set for October 26, 2022; proxy materials to be mailed around September 20.
Net proceeds to support working capital and general corporate purposes.

item 3.02 item 5.02 item 8.01 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stavros Vizirgianakis

Chairman of the Board

XTNT · Xtant Medical Holdings, Inc.

Effective: 2022-08-31
Filed: August 31, 2022, 7:59 PM ET

the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders

Role change

Jeffrey Peters

Chairman of the Board

XTNT · Xtant Medical Holdings, Inc.

Effective: 2022-08-31
Successor: Stavros Vizirgianakis
Filed: August 31, 2022, 7:59 PM ET

the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stavros Vizirgianakis was appointed as Chairman of the Board at Xtant Medical Holdings, Inc..

Action: appointed
Role: Chairman of the Board

Exact text from the filing

the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Peters changed role as Chairman of the Board at Xtant Medical Holdings, Inc..

Action: replaced
Role: Chairman of the Board

Exact text from the filing

the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders

View on SEC.gov

Xtant Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-024444

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.